Distinguished Plenary Speakers
Click here to view plenary speaker biographies
Jan Vilcek, Ph.D., Remicade Co-Inventor and Professor of Microbology, NYU School of Medicine
Biotechnology Then and Now: A Personal Perspective
Dr. Vilcek has dedicated his entire career to pioneering studies of soluble mediators that regulate the immune system. In collaboration with Dr. Junming Le and Centecor Inc. Dr. Vilcek developed Remicade®, a powerful anti-inflammatory used in the treatment of rheumatoid arthritis, Crohn's disease and other inflammatory diseases. Dr. Vilcek also recently donated $105 million to the New York University School of Medicine, the largest gift ever made to the school and possibly the largest philanthropic gift from an active faculty member to an a academic medical center. Come and hear Dr. Vilcek speak of his passion for his research and his career path. Be inspired!
Neil Gibson, Ph.D. Chief Scientific Officer, OSI Pharmaceuticals, Inc.
Cancer therapeutics in the 21st century
OSI Pharmaceuticals is a leading biotechnology company primarily focused on the discovery, development and commercialization of high quality pharmaceutical products that extend the life or improve the quality-of-life for cancer and diabetes patients worldwide. The success of OSI's Tarceva positions them at the forefront of a paradigm-shifting movement toward more targeted and better-tolerated therapies. Do not miss Dr. Gibson's visionary plenary that discusses the future of cancer therapeutics and the direction for research and development.
Bill Fair, Managing Director -Healthcare and Biosciences. New York City Economic Development Corporation
New York City - A Leading Hub for the Biosciences
New York City has everything you need for success in the Bioscience industry: world-renowned research, talent and resources no other city can offer. The city is a dynamic center of opportunity and possibilities. Gain insights into what makes New York City a world class hub for the biosciences. Hear first hand how to capitalize on the city’s assets to fuel your career. Don’t miss an eye-opening and thought-provoking plenary that dives into the nuts and bolts of how to succeed in New York City.
Jack Linehan, Ph.D. Executive Faculty, Program in Biodesign, Stanford University. Former Vice President, The Whitaker Foundation
Innovation for the Future
The integration of mathematics, chemistry and physics with modern biology is a new discipline. For this new discipline, all of the elements for success seem to be at hand. Barriers to educational innovations are at an all time low. A new information portal; Bmesource.org, is being developed with help of students. Hear how “innovation” is being effectively “taught” in academia, a presentation that will provide an invigorating view of the future of science and academia.
Panel Chairs
Click here to view panel chair biographies
Patrick T. Connor, Ph.D.,Associate Director, SLS, Pall Corp.
Anil Dhundale, Ph.D. Director for Scientific Affairs, Center for Biotechnology
Diane Fabel, Director of Operations, Center for Biotechnology
Ron Guido, Director, Worldwide Regulatory Strategy, Global Regulatory Leader. Pfizer, Inc
Julie Huang, Sr. VP, Life Sciences. Financial Dynamics Business Communications
Cynthia Isaac, Ph.D., Vice President Ogilvy PR Worldwide
Cliff Mintz, Ph.D., CEO, BioInsights
Iesha O'Deneal, Manager, Diversity Programs, New York Academy of Sciences.
Clinton T. Rubin, Ph.D. Professor and Chair, Dept. of Biomedical Engineering, Stony Brook University and Director, Center for Biotechnology
Charles Ryan, JD, PhD, Vice President, Chief Intellectual Property Counsel, Forest Research Institute, Inc.
Marianna Savoca, Director, Stony Brook University Career Center
Joseph Scaduto, Executive Director, Long Island Life Sciences Initiative
Ramana Sonty, Ph.D. Senior Director/Team Leader, Global Project Management NY, Pfizer, Inc
Charla Triplett, National Director, BME AII
Jeff Yablon, Principal, Yablon Management Consulting, former CEO at Icon Laboratories
Panel Speakers
Click here to view Panel Speaker biographies
Hot Trends in Biomedical Engineering Research
Panel Chair: Charla Triplett, National Director, Biomedical Engineering Alliance
Marom Bikson, Assistant Professor, Biomedical Engineering, The City College of New York
Ashutosh Sharma, Ph.D., Vice President, Product and Process Development, Vyteris
Andrew Tsourkas, Ph.D., Assistant Professor of Bioengineering, Assistant Professor of Radiology, University of Pennsylvania
Regulatory Affairs: An Evolving Role in Pharmaceutical and Biotechnology Development
Panel Chair: Ron Guido, Director, Worldwide Regulatory Strategy, Global Regulatory Leader, Pfizer, Inc.
Alan McEmber, Director, Worldwide Regulatory Strategy, Pfizer
MaryEllen Norvich, Director, Worldwide Regulatory Strategy, Pfizer
Successful Foundation, Industry and Academic Partnerships
Panel Chair: Clinton T. Rubin, Ph.D., Professor and Chair, Dept. of Biomedical Engineering, Stony Brook University and Director, Center for Biotechnology
Victor Frankel M.D., Ph.D. Professor / President, Departments of Hospital for Joint Diseases and Orthopedic Surgery
John Ghrayeb, Ph.D., Vice President Vice President, Licensing and New Business Development, Centocor, Inc. / Johnson & Johnson
Maria Gotsch, Co-Chief Executive Officer and Co-President of the New York City Investment Fund
Everything You Need to Know About Finding a Job in the Life Sciences Industry
Panel Chair: Cliff Mintz, Ph.D., CEO, BioInsights
Jack Chirkjian, Ph.D., Professor and Head, Georgetown University MA Program in Biotechnology
Grace Wong, Ph.D., Founder and Chief Scientific Officer, Actokine Therapeutics.
Alternative Careers for Life Science Graduates
Panel Chair: Cynthia Isaac, Ph.D., Vice President, Ogilvy PR Worldwide
Jason Alter, Ph.D., Vice President Marketing & Services, Turboworx
Ellyn Kerr, Managing Editor, Industrial Biotechnology
Lorence Kim, MD, Vice President, Head of Global Biotechnology Practice, Goldman Sachs
Agony or Ecstasy
Panel Chair: Anil Dhundale, Ph.D. Director for Scientific Affairs, Center for Biotechnology
Randall Barbour, Ph. D. Chief Executive Officer, NIRx Medical Technologies
Lee Chen, Director, Operations and Marketing, Vitatex, Inc.
Ron Cohen, MD, CEO, Acorda Therapeutics
Career Pathways in Biomedical Engineering
Panel Chair: Charla Triplett, National Director, Biomedical Engineering Alliance
Angela Collison; M.S.,Scientific Advisor, Frommer Lawrence & Haug, LLP
Y. Emre Erdi, D.Sc., DABR, Memorial Sloan Kettering Cancer Center
Tamara Kaplan; M.S., Ventana Medical Systems (VMSI)
Sameer Karnick; M.S., Cornerstone Pharmaceuticals
Jay Ramachandran; M.S. GAC International. Corporate Product Development
From the Bench to the Bar
Panel Chair: Charles Ryan, Ph.D., JD, Vice President, Chief Patent Counsel, Forest Research Institute, Inc.
Philip Braginsky, Counsel, Sills Cummis Epstein & Gross P.C.
Yongzhi (Mimi) Yang Associate, Intellectual Property Law, Scully Scott Murphy and Presser, PC
Start-Up 101
Panel Chair: Anil Dhundale, Ph.D. Director for Scientific Affairs, Center for Biotechnology.
Sandra Panem, Ph.D., Partner, Cross Atlantic Partners
Clinton T. Rubin, Ph.D., Chairman, Dept of Biomedical Engineering, Stony Brook University, and Scientific Founder, Exogen, Juvent, and AcousticScan
Biomedical Engineering in the Life Sciences
Panel Chair: Charla Triplett, National Director, Biomedical Engineering Alliance
Anil Dhundale, Ph.D. Director for Scientific Affairs, Center for Biotechnology.
Treena Livingston Arinzeh, Assistant Professor of Biomedical Engineering, NJIT
Jeffrey W. Holmes M.D., Ph.D., Associate Professor, Department of Biomedical Engineering, Columbia University
The Grass is Greener on the “Other Side”
Panel Chair: Angeline Judex, Asst. Dir, Communications and Programs, Center for Biotechnology
Sandra P. Kim, Ph.D., Senior Specialist, NY Patent Department, Pfizer, Inc.
Kira S.Sheinerman, Ph.D., VP Investment Banking, Rodman & Renshaw, LLC
Eric Staeva-Vieira, PhD, Associate biotechnology analyst at Rodman & Renshaw LLC
Accessing Capital Markets for Life Science Companies
Panel Chair: Anne Marie Scheidt, Ph.D., Director, Economic Development, Stony Brook University
Pete Meyers, Co-Head Life Science Banking, Deutsche Bank
Carlos N. Valez, Erie Hudson Life Science Consulting
Alex Zisson, Venture Partner, Thomas, McNerney & Partners
Women in the Life Sciences
Panel Chair: Iesha O'Deneal, Manager, Diversity Programs New York Academy of Sciences
Sadhana Chitale, Ph.D., Business Development Analyst, NYU School of Medicine
Joanne Deyo, CFM, Senior Director, Facilities, Regeneron Pharmaceuticals, Inc.
Monique Salazar, Assistant Vice President for Bioscience, New York City Economic Development Corporation (NYCEDC)
Janine Schwedes, MBA, Manager, Scientific Affairs, OSI Pharmaceuticals, Inc.
Innovations & Challenges Facing Product Development in the Life Sciences
Panel Chair: Ramana Sonty, Ph.D., Senior Director/ Team Leader, Global Project Management NY, Pfizer Global Pharmaceuticals
Jonathan Garen, MBA, Director, Business Development, Forest Laboratories, Inc.
Lata Jayaraman, Ph.D., Senior Research Investigator, Oncology Drug Discovery, Bristol-Myers Squibb Pharmaceutical Research Institute
Shama M. Kajiji, Ph.D. MBA, Director, Global Project Management & Head, Attrition Analysis Office, Pfizer Global Research and Development
John Lepore, Ph.D., Senior Director, Chemical Engineering R&D, Merck Research Laboratories
Resources That Help “Bridge the Gap”
Panel Chair: Anil Dhundale, Ph.D. Director for Scientific Affairs, Center for Biotechnology
Jim Denn, Director of Operations of the New York State Office of Science, Technology and Academic Research (NYSTAR).
Franklin Madison, Jr., Technology Program Director, ITAC
Joseph Scaduto, Executive Director, Long Island Life Sciences Initiative
Corporate Culture – Defining the Rules of the Game
Panel Chair: Patrick T. Connor, Ph.D, Associate Director, Scientific and Laboratory Services Dept. (SLS), Pall Corp.
John Jarres, Laboratory Manager, SLS, Pall Corp.
Mary Kuskin, Director Regulatory Affairs, Pfizer inc.
Santhosh Vadivelu, Ph.D. Cold Spring Harbor Laboratory
Keith Ward, Ph.D, Vice President, Global Pre-clinical Research, Bausch & Lomb
Business Development as a Career– Three Very Different Perspectives
Panel Chair: Jeff Yablon, Principal, Yablon Management Consulting, Founder and COO PharmaScan Clinical Trials LLC
Lorrence Green, Ph.D., President, Westbury Diagnostics Inc
Richard Purcell, President, Clinpro, Inc.
Gary Shangold, MD., CEO, NovaDel Pharmaceuticals, Inc.
Public and Investor Communications: What You Don’t Know Can Hurt You
Panel Chair: Julie Huang, Sr. VP Life Sciences, Financial Dynamics Business Communications
Chau Cheng, Ph.D., Director, Investor Relations, Immunomedics
Robert Feeney, Associate Director of Corporate Planning and Communication, Eisai, Inc.
Cynthia Isaac, Ph.D., Vice President, Ogilvy PR Worldwide
Finding New Talent; Recruiting New Graduates
Panel Chair: Marianna Savoca, Director, Stony Brook University Career Center
Alfreda James, Internship Manager, Stony Brook University Career Center
Mark Savage, Cornell University
Roly Boyon, Senior Recruiter, Forest Laboratories, Inc
Networking: Important at All Stages of Career and Corporate Development
Panel Chair: Julie Huang, Sr. VP Life Sciences, Financial Dynamics Business Communications
Sandra Holtzman, President, Holtzman Communications
Joseph Scaduto, Executive Director, Long Island Life Sciences Initiative
Matthew Wotiz, Associate Director, US Business Development and Licensing. Lundbeck, Inc.
|
